Latest Callisto Pharmactls (CLSP) Headlines N
Post# of 2
Posted On: 03/09/2014 8:48:05 AM
Latest Callisto Pharmactls (CLSP) Headlines
NEC launches new DCMStar/ChainStore solution for international chain retailers
M2 - Wed Jan 15, 6:27AM CST
NEC Corporation (NEC; TSE: 6701) today announced the launch of a new addition to its lineup of DCMStar/ChainStore solutions for international retailers (chain stores) in the Asia Pacific (APAC) region and elsewhere. Primary functions of the new product include the provision of product order recommendations, a function providing real-time access to sales and inventory information from each store, and a CRM function that can be used to implement a wide variety of point card services.
2013 Report on the International Push to Talk Telemedicine and M-Health Convergence - Forecasts to 2019
M2 - Wed Jan 15, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/m7mhgx/push_to_talk) has announced the addition of a new report "2013 Report on the International Push to Talk Telemedicine and M-Health Convergence - Forecasts to 2019" to their offering. PTT telemedicine markets are poised to achieve significant growth as the existing telemedicine systems merge with the smart phone systems of engagement to provide a way to improve clinical care delivery to patients with chronic disease, decreasing hospitalizations and visits to the emergency room. There is a convergence of telemedicine and m-health as the patients become more responsible for their own care delivery and their own health. There is a convergence of telemedicine and m-health as the patient uses push to talk devices in telemonitoring situations where the sensor data is transmitted to a facility, encouraging the patient to become more responsible for their own care delivery and their own health. Healthcare patient, physician, and facility decision support markets are forecast based n the broad availability of smartphones combined with the IBM Watson technology that Watson offers Interactive Care Insights for Oncology. Telemedicine push to talk PTT dedicated device and software markets at $214 million in 2012 are anticipated to reach $4.4 billion by 2019. M-Health markets related to telemedicine at $1.4 billion are anticipated to reach $1.5 trillion by 2019 due to the leveraging of 8.5 billion smart phones and 5 billion connected tablet devices all over the world. Key Topics Covered: 1. Telemedicine and M-Health Market Description and Market Dynamics 2. Tele-Medicine / M-Health Market Shares and Market Forecasts 3. Telemedicine / M-Health Product Description 4 . Tele-Monitor Technology 5. Telemedicine / M-Health Company Profiles Companies Mentioned: - AT&T - Apple - Biotronik - Bosch Group - CMO, The Care Management Company - Debiotech - Family Home Care - FuzeBox - Glaxo Smith Kline - Google - Honeywell - IBM - Infopia - JSC CEM Technology - KSB Home Health - LG - Logitech - Medtronic - Microsoft - Nonin Medical, Inc. - Partners Healthcare - Philips - REACH Health, Inc. - RS TechMedic BV - Royal Philips Revenue - STMicroelectronics - Samsung - Sandata Technologies, Inc. - TeleAtrics - University of Houston - VIDAVO S.A - Vodafone - WellPoint: Independent Licensee Blue Cross and Blue Shield Association For more information visit http://www.researchandmarkets.com/research/m7...sh_to_talk
Synergy Pharmaceuticals Inc concludes merger agreement with Callisto Pharmaceuticals Inc today
M2 - Fri Jan 18, 5:16AM CST
Drug company Synergy Pharmaceuticals Inc (NasdaqCM:SGYP) reported on Thursday the completion of its merger with Callisto Pharmaceuticals Inc (formerly OTC QB:CLSP) from a previous agreement.
Synergy Pharmaceuticals Announces Closing of Merger With Callisto Pharmaceuticals
GlobeNewswire - Thu Jan 17, 3:05PM CST
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its previously announced merger with Callisto Pharmaceuticals, Inc. (formerly OTC QB: CLSP) closed effective today.
Callisto Announces Adjournment of Special Meeting
GlobeNewswire - Thu Jan 03, 3:31PM CST
Callisto Pharmaceuticals, Inc. (OTCBB:CLSP) ("Callisto") today announced that it convened its special meeting of stockholders on Thursday, January 3, 2013 and adjourned the meeting until Monday, January 14, 2013, at 1:00 p.m., Eastern Standard Time. The special meeting was adjourned to allow the company's stockholders a reasonable amount of time to consider the recent announcement, by Synergy Pharmaceuticals Inc., of the results of its Phase IIb/III clinical trial.
NEC launches new DCMStar/ChainStore solution for international chain retailers
M2 - Wed Jan 15, 6:27AM CST
NEC Corporation (NEC; TSE: 6701) today announced the launch of a new addition to its lineup of DCMStar/ChainStore solutions for international retailers (chain stores) in the Asia Pacific (APAC) region and elsewhere. Primary functions of the new product include the provision of product order recommendations, a function providing real-time access to sales and inventory information from each store, and a CRM function that can be used to implement a wide variety of point card services.
2013 Report on the International Push to Talk Telemedicine and M-Health Convergence - Forecasts to 2019
M2 - Wed Jan 15, 6:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/m7mhgx/push_to_talk) has announced the addition of a new report "2013 Report on the International Push to Talk Telemedicine and M-Health Convergence - Forecasts to 2019" to their offering. PTT telemedicine markets are poised to achieve significant growth as the existing telemedicine systems merge with the smart phone systems of engagement to provide a way to improve clinical care delivery to patients with chronic disease, decreasing hospitalizations and visits to the emergency room. There is a convergence of telemedicine and m-health as the patients become more responsible for their own care delivery and their own health. There is a convergence of telemedicine and m-health as the patient uses push to talk devices in telemonitoring situations where the sensor data is transmitted to a facility, encouraging the patient to become more responsible for their own care delivery and their own health. Healthcare patient, physician, and facility decision support markets are forecast based n the broad availability of smartphones combined with the IBM Watson technology that Watson offers Interactive Care Insights for Oncology. Telemedicine push to talk PTT dedicated device and software markets at $214 million in 2012 are anticipated to reach $4.4 billion by 2019. M-Health markets related to telemedicine at $1.4 billion are anticipated to reach $1.5 trillion by 2019 due to the leveraging of 8.5 billion smart phones and 5 billion connected tablet devices all over the world. Key Topics Covered: 1. Telemedicine and M-Health Market Description and Market Dynamics 2. Tele-Medicine / M-Health Market Shares and Market Forecasts 3. Telemedicine / M-Health Product Description 4 . Tele-Monitor Technology 5. Telemedicine / M-Health Company Profiles Companies Mentioned: - AT&T - Apple - Biotronik - Bosch Group - CMO, The Care Management Company - Debiotech - Family Home Care - FuzeBox - Glaxo Smith Kline - Google - Honeywell - IBM - Infopia - JSC CEM Technology - KSB Home Health - LG - Logitech - Medtronic - Microsoft - Nonin Medical, Inc. - Partners Healthcare - Philips - REACH Health, Inc. - RS TechMedic BV - Royal Philips Revenue - STMicroelectronics - Samsung - Sandata Technologies, Inc. - TeleAtrics - University of Houston - VIDAVO S.A - Vodafone - WellPoint: Independent Licensee Blue Cross and Blue Shield Association For more information visit http://www.researchandmarkets.com/research/m7...sh_to_talk
Synergy Pharmaceuticals Inc concludes merger agreement with Callisto Pharmaceuticals Inc today
M2 - Fri Jan 18, 5:16AM CST
Drug company Synergy Pharmaceuticals Inc (NasdaqCM:SGYP) reported on Thursday the completion of its merger with Callisto Pharmaceuticals Inc (formerly OTC QB:CLSP) from a previous agreement.
Synergy Pharmaceuticals Announces Closing of Merger With Callisto Pharmaceuticals
GlobeNewswire - Thu Jan 17, 3:05PM CST
Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its previously announced merger with Callisto Pharmaceuticals, Inc. (formerly OTC QB: CLSP) closed effective today.
Callisto Announces Adjournment of Special Meeting
GlobeNewswire - Thu Jan 03, 3:31PM CST
Callisto Pharmaceuticals, Inc. (OTCBB:CLSP) ("Callisto") today announced that it convened its special meeting of stockholders on Thursday, January 3, 2013 and adjourned the meeting until Monday, January 14, 2013, at 1:00 p.m., Eastern Standard Time. The special meeting was adjourned to allow the company's stockholders a reasonable amount of time to consider the recent announcement, by Synergy Pharmaceuticals Inc., of the results of its Phase IIb/III clinical trial.
(0)
(0)Callisto Pharmactls (CLSP) Stock Research Links
Scroll down for more posts ▼